Stock Market Stories and Insights

USAP
  2 days ago at Macroaxis 
By Raphi Shpitalnik
Today we may see the proof that Arcelormittal ADR would recover much slower from the newest drop as its shares went up 0.66% to Universal Stainles's 8.1788%. As many rational traders are trying to avoid basic materials space, it makes sense to recap Universal Stainles a little further and understand how it stands against Arcelormittal ADR and other similar entities. We are going to focus on some of the competitive aspects of both Universal and Arcelormittal.
HIVE
  2 days ago at Macroaxis 
By Vlad Skutelnik
Hive Blockchain Enterprise Value is projected to increase significantly based on the last few years of reporting. The past year's Enterprise Value was at 193.93 Million. The current year Free Cash Flow is expected to grow to about 12.9 M, whereas Revenue Per Employee is forecasted to decline to about 272.7 K. As many baby boomers are still indifferent towards technology space, it makes sense to digest Hive Blockchain Technologies. We will analyze why it could be a much better year for Hive Blockchain shareholders. In this post, I will also go over a few different drivers affecting Hive Blockchain's products and services, and explain how it may impact Hive Blockchain shareholders.
MNTK
  2 days ago at Macroaxis 
By Vlad Skutelnik
The upcoming quarterly report is expected on the 15th of November 2021. The stock continues to go through an active upward rally. While many traders are getting carried away by overanalyzing utilities space, it is reasonable to examine Montauk Renewables under the recent economic conditions. Should we be more optimistic in anticipation of a recovery?
BTTR
  2 days ago at Macroaxis 
By Gabriel Shpitalnik
Better Choice Return on Average Equity is relatively stable at the moment as compared to the past year. Better Choice reported last year Return on Average Equity of 3.31. As of 10/15/2021, Tangible Assets Book Value per Share is likely to grow to 2.45, while Earnings before Tax are likely to drop (60.9 M). The fundamental reasoning behind this short post is to break down our forecasting of Better for retail investors. We will try to forecast Better Choice outlook for November.
DBVT
  2 days ago at Macroaxis 
By Raphi Shpitalnik
As many rational traders are trying to avoid healthcare space, it makes sense to review DBV Technologies S a little further and understand how it stands against Brickell Biotech and other similar entities. We are going to break down some of the competitive aspects of both DBV Technologies and Brickell.
WVE
  2 days ago at Macroaxis 
By Raphi Shpitalnik
While many traders are getting carried away by overanalyzing healthcare space, it is reasonable to digest Wave Life Sci. We will cover the possibilities of making Wave Life into a steady grower in November. In this post, I will also go over a few different drivers affecting Wave Life's products and services, and explain how it may impact Wave Life shareholders.
DTEA
  2 days ago at Macroaxis 
By Gabriel Shpitalnik
While some of us are excited about consumer defensive space, it makes sense to go over Davidstea in greater detail to make a better perception of its potential. As expected, Davidstea is starting to reaffirm its true potential as investors are becoming more and more confident in the future outlook. A lot of the movements of the company stock price movements has been a reflection of what is happening in the market overall. The appearance of strong technical and fundamental indicators of the company suggests a short-term price swing for investors of Davidstea. The next fiscal quarter end is expected on the 31st of October 2021. The stock is undergoing an active upward rally.
ONCS
  2 days ago at Macroaxis 
By Raphi Shpitalnik
As many rational traders are trying to avoid healthcare space, it makes sense to sum up Oncosec Medical a little further and understand how it stands against Biontech and other similar entities. We are going to discuss some of the competitive aspects of both Oncosec and Biontech.
MARA
  2 days ago at Macroaxis 
By Ellen Johnson
The upcoming quarterly report is expected on the 11th of November 2021. The stock is undergoing an active upward rally. As some millenniums are still trying to avoid financial services space, I will try to go over Marathon Digital Hldgs a little further in order to understand its potential as a viable investment. We will evaluate why recent Marathon Digital price moves suggest a bounce in November.
EVA
  2 days ago at Macroaxis 
By Ellen Johnson
Enviva Partners Free Cash Flow is projected to increase significantly based on the last few years of reporting. The past year's Free Cash Flow was at 19.23 Million. The current year Working Capital is expected to grow to about 35.9 M, whereas Average Assets are forecasted to decline to about 1.1 B. While many traders are getting carried away by overanalyzing basic materials space, it is reasonable to go over Enviva Partners LP. We will analyze why it could be a much better year for Enviva Partners shareholders. In this post, I will also go over some essential variables affecting Enviva Partners' products, and show how it may impact Enviva Partners outlook for active traders this year.